Trisalus Life Sciences, Inc. · NASDAQ:TLSI

Mats Wahlstrom reported a 6.00% stake in Trisalus Life Sciences, Inc. (Schedule 13D/A)

Event Jul 31, 2025 · Filed Aug 1, 2025

Mats Wahlstrom reported a 6.00% stake in Trisalus Life Sciences, Inc., 2,987,881 shares, with active intent on Jul 31, 2025. Filed Aug 1, 2025 (Schedule 13D/A).

Stake
6.00%
Shares
2,987,881
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Mats Wahlstrom6.00%2,987,881
Kerry R. Hicks4.70%2,349,795
HW Investment Partners, LLC2.80%1,370,028
HW Investment Partners, LLC2.80%1,370,028

Source

View original at SEC

Related